19-10961163-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_003072.5(SMARCA4):c.-43C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00272 in 147,894 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SMARCA4
NM_003072.5 5_prime_UTR_premature_start_codon_gain
NM_003072.5 5_prime_UTR_premature_start_codon_gain
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.935
Publications
0 publications found
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 19-10961163-C-T is Benign according to our data. Variant chr19-10961163-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 328016.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00272 (402/147894) while in subpopulation NFE AF = 0.00356 (236/66364). AF 95% confidence interval is 0.00318. There are 2 homozygotes in GnomAd4. There are 181 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.-40C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 36 | ENST00000646693.2 | NP_001374212.1 | ||
SMARCA4 | NM_003072.5 | c.-43C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 35 | ENST00000344626.10 | NP_003063.2 | ||
SMARCA4 | NM_001387283.1 | c.-40C>T | 5_prime_UTR_variant | Exon 1 of 36 | ENST00000646693.2 | NP_001374212.1 | ||
SMARCA4 | NM_003072.5 | c.-43C>T | 5_prime_UTR_variant | Exon 1 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.-40C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 36 | NM_001387283.1 | ENSP00000495368.1 | ||||
SMARCA4 | ENST00000344626.10 | c.-43C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
SMARCA4 | ENST00000643549.1 | c.-40C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 35 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.-203C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 35 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.-43C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 34 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.-40C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 34 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.-272C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 35 | 5 | ENSP00000464778.1 | ||||
SMARCA4 | ENST00000646693.2 | c.-40C>T | 5_prime_UTR_variant | Exon 1 of 36 | NM_001387283.1 | ENSP00000495368.1 | ||||
SMARCA4 | ENST00000344626.10 | c.-43C>T | 5_prime_UTR_variant | Exon 1 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
SMARCA4 | ENST00000643549.1 | c.-40C>T | 5_prime_UTR_variant | Exon 1 of 35 | ENSP00000493975.1 | |||||
SMARCA4 | ENST00000541122.6 | c.-203C>T | 5_prime_UTR_variant | Exon 1 of 35 | 5 | ENSP00000445036.2 | ||||
SMARCA4 | ENST00000643296.1 | c.-43C>T | 5_prime_UTR_variant | Exon 1 of 34 | ENSP00000496635.1 | |||||
SMARCA4 | ENST00000644737.1 | c.-40C>T | 5_prime_UTR_variant | Exon 1 of 34 | ENSP00000495548.1 | |||||
SMARCA4 | ENST00000589677.5 | c.-272C>T | 5_prime_UTR_variant | Exon 1 of 35 | 5 | ENSP00000464778.1 |
Frequencies
GnomAD3 genomes AF: 0.00272 AC: 402AN: 147786Hom.: 2 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
402
AN:
147786
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 30Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 24
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
30
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
24
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
AC:
0
AN:
20
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
0
AN:
8
Other (OTH)
AF:
AC:
0
AN:
2
GnomAD4 genome AF: 0.00272 AC: 402AN: 147894Hom.: 2 Cov.: 31 AF XY: 0.00251 AC XY: 181AN XY: 72168 show subpopulations
GnomAD4 genome
AF:
AC:
402
AN:
147894
Hom.:
Cov.:
31
AF XY:
AC XY:
181
AN XY:
72168
show subpopulations
African (AFR)
AF:
AC:
31
AN:
40716
American (AMR)
AF:
AC:
51
AN:
14978
Ashkenazi Jewish (ASJ)
AF:
AC:
70
AN:
3414
East Asian (EAS)
AF:
AC:
0
AN:
5004
South Asian (SAS)
AF:
AC:
1
AN:
4774
European-Finnish (FIN)
AF:
AC:
2
AN:
9414
Middle Eastern (MID)
AF:
AC:
3
AN:
268
European-Non Finnish (NFE)
AF:
AC:
236
AN:
66364
Other (OTH)
AF:
AC:
8
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
24
48
72
96
120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 28, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Coffin-Siris syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.